Recce Pharmaceuticals Ltd. AI Stock Analysis
Recce Pharmaceuticals Ltd. (R9Q) AI Stock Analysis
Recce Pharmaceuticals Ltd.
(Frankfurt:R9Q)
No summary available
Recce Pharmaceuticals Ltd. (R9Q) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 114.72M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -7.2
- Beta (1Y)
- 0.87
- Revenue Growth
- ―
- EPS Growth
- 45.78%
- Country
- Germany
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Recce Pharmaceuticals Ltd. Business Overview & Revenue Model
Company Description
Recce Pharmaceuticals Ltd operates as a biotechnology enterprise, concentrating on the research, advancement, and market introduction of synthetic anti-infective treatments across Australia, the United States, and the United Kingdom. The company's fo...
Recce Pharmaceuticals Ltd. Peers Comparison
Overall Rating
AU:BIO69Neutral
AU:IMC45Neutral
AU:BIT43Neutral
AU:SPL40Underperform
AU:BOT38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | AUD 79.84M | 19.88 | 46.74% | ― | 29.68% | 1520.00% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | AUD 11.95M | -2.87 | -31.88% | ― | 5.85% | 45.13% | |
| 43Neutral | AUD 4.18M | -3.56 | -54.03% | ― | ― | -100.00% | |
| 40Underperform | AUD 200.41M | -24.56 | -42.35% | ― | 145.32% | 25.75% | |
| 38Underperform | AUD 27.63M | -0.25 | -118.74% | ― | 499.47% | 31.20% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:R9Q | Recce Pharmaceuticals Ltd. | 0.21 | -0.00 | -1.90% | |
| AU:BIT | Biotron Limited | ― | ― | ― | |
| AU:SPL | Starpharma Holdings Limited | 0.42 | 0.04 | 10.82% | |
| AU:IMC | Immuron Limited | 0.04 | -0.03 | -43.08% | |
| AU:BOT | Botanix Pharmaceuticals Limited | 0.01 | -0.11 | -91.30% | |
| AU:BIO | Biome Australia Ltd | 0.32 | -0.07 | -17.95% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
